Source:http://linkedlifedata.com/resource/pubmed/id/16110216
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2005-8-19
|
pubmed:abstractText |
Targeting antigens to antigen-presenting cells by fusion to cytotoxic T lymphocyte-associated antigen 4 (CTLA4) has been shown to be a highly efficient method to enhance the efficacy of DNA vaccines. The purpose of this study was to determine the immunogenicity and protective efficacy of the targeted fusion DNA construct pGJA-P, which contains the signal peptide and extracellular regions of human CTLA4 gene, the hinge and Fc regions of human Iggamma1 gene, the glucan-binding domain of the Streptococcus mutans gtfB gene and the A-P fragment of the S. mutans pac gene, compared with the fusion DNA construct pGLUA-P, which contains only the glucan-binding domain of the S. mutansgtfB gene and the A-P fragment of the S. mutans pac gene. BALB/c mice were immunized with pGJA-P, pGLUA-P, or pCI (vector) by the intramuscular or intranasal route. Specific anti-PAc and anti-GTF-I serum IgG and salivary IgA antibody responses were assessed by an enzyme-linked immunosorbent assay. Wistar rats were orally challenged with S. mutans and immunized with pGJA-P, pGLUA-P, or pCI intramuscularly or intranasally, and caries activity was evaluated by the Keyes method. pGJA-P induced accelerated and increased serum and salivary antibody responses in mice compared with pGLUA-P. Rats immunized with pGJA-P had significantly fewer caries lesions than rats immunized with pGLUA-P (p < 0.01). Thus, this study demonstrates that the targeted DNA construct pGJA-P can enhance both systemic and mucosal immunity and may be a useful strategy for improving the protective efficacy of anticaries DNA vaccines.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
D
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0008-6568
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright (c) 2005 S. Karger AG, Basel.
|
pubmed:issnType |
Print
|
pubmed:volume |
39
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
422-31
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16110216-Animals,
pubmed-meshheading:16110216-Antigen-Presenting Cells,
pubmed-meshheading:16110216-Bacteriocin Plasmids,
pubmed-meshheading:16110216-Dental Caries,
pubmed-meshheading:16110216-Female,
pubmed-meshheading:16110216-Humans,
pubmed-meshheading:16110216-Immunoconjugates,
pubmed-meshheading:16110216-Immunoglobulin G,
pubmed-meshheading:16110216-Mice,
pubmed-meshheading:16110216-Mice, Inbred BALB C,
pubmed-meshheading:16110216-Rats,
pubmed-meshheading:16110216-Rats, Wistar,
pubmed-meshheading:16110216-Saliva,
pubmed-meshheading:16110216-Streptococcal Infections,
pubmed-meshheading:16110216-Streptococcus mutans,
pubmed-meshheading:16110216-Vaccines, DNA
|
pubmed:articleTitle |
Immunogenicity and protective efficacy of a targeted fusion DNA construct against dental caries.
|
pubmed:affiliation |
Key Laboratory of Oral Biomedical Engineering, Stomatological College of Wuhan University, Wuhan, Hubei, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|